Ryan Hummer
Analyst · Simmons. Your line is open
Thank you, Robert. As reflected in yesterday's earnings release, our fourth quarter revenues were $40.2 million unchanged compared to $50.2 million in the prior year's fourth quarter. We saw a significant increase in our U.S. revenue of 36% and our international revenue of over 400% as compared to last year's fourth quarter. These were fully offset by a decrease in our Canadian revenue. On a sequential basis, revenue in the fourth quarter was 20% lower than revenue in the third quarter with a sequential increase in the U.S. revenue of 4% more than offset by sequential declines in Canada and international markets. Gross profit defined as total revenue less total cost of sales excluding depreciation and amortization expense was $24.2 million in the fourth quarter or 48% of revenue compared to $25.6 million or 51% of revenue in the prior year's fourth quarter with higher margins for product sales offset by lower margins on services revenue. This gross margin percentage was in line with the midpoint of the guidance we provided for the quarter and reflected the pricing actions that we initiated in the Canadian market during the quarter. For sequential comparison, gross profit was $33.9 million or 54% of revenue in the third quarter of 2018. As we move into the first quarter of 2019, we continue to expect our gross margins to be between 46% and 50%, before we see the benefit from the full commercialization of our lower cost family of sleeves in the second half of the year. Selling, general and administrative costs increased to $20.3 million in the fourth quarter from $18.1 million in the prior year's fourth quarter and increased from the third quarter's level of $19.4 million. As a reminder, our reported SG&A includes share-based compensation as well as certain non-recurring expenses. The year-over-year increase was primarily driven by headcount additions as well as increases to share-based compensation. The increase relative to the third quarter was primarily driven by a smaller reduction to our bonus accrual in the fourth quarter as compared to the reduction that we made in the third quarter. For the first quarter of 2019, we expect our reported SG&A inclusive of share-based compensation and non-recurring items to be between $22 million and $23 million. The increase compared to the fourth quarter will primarily be driven for the positive accrual of bonuses under our 2019 plan as compared to the reversal in each of the third and fourth quarter of 2018, which we made as market conditions deteriorated. We also expect to incur higher costs related to ongoing litigation matters, higher share based compensation expense and support costs related to our recent ERP system implementation. NCS management is committed to ensuring that our costs are aligned with our current operating environment and it is managing SG&A to ensure that we are getting the appropriate return from the investments we are making in our sales infrastructure and research and development efforts. Our fourth quarter 2018 depreciation and amortization expense totaled $4.5 million. We expect our first quarter depreciation and amortization expense to be between $2.5 million and $3 million with higher depreciation expense offset by reduced amortization related to the impairment charges to intangible assets, which I'll discuss in more detail in a second. Adjusted EBITDA for the fourth quarter was $7.8 million as compared to $10.4 million in the prior year's fourth quarter. Adjusted EBITDA as a percentage of total revenue was 15% in the fourth quarter of 2018. A couple of other items to note with respect to our income statement in the fourth quarter. First, as indicated in our pre-release, we recorded a non-cash impairment charge totaling $227.5 million during December. This included over $70 million in impairments to intangible assets. As a result of the impairments, our annual amortization expense will be reduced by nearly $9 million to an estimated $4.5 million for the full year 2019. We also recorded impairments to goodwill totaling over $150 million which will not impact the income statement going forward. Second, we recorded non-cash expense of $0.1 million in the quarter which reflected an increase to the liability that we have on our balance sheet related to the contingent earn out provision associated with Repeat Precision. At the end of the year, we determined that Repeat Precision earned the full earn out amount of $10 million with NCS making a $10 million contribution to the joint venture, which was subsequently distributed to our partner in January of 2019. Third, our book effective tax rate for the quarter was a benefit of 11.5%. The calculation of our book tax rate included adjustments related to our impairments as well as U.S. tax reform. Fourth, we had net income attributable to non-controlling interest of $1.5 million in the quarter reflecting positive net income at Repeat Precision. We expect to continue to have positive contributions from repeat in 2019 and into the future. When considering our net income and earnings per share in future periods, it's important to account for these contributions. For calibration, the net income attributable to non-controlling interest has been approximately 5.5% of our U.S. revenue in the last two quarters. And we expect it to maintain at that level or perhaps increase slightly with the continued success of the purple seal product line and the Purple Seal Express offering. Finally, the remaining outstanding exchangeable shares were converted into common shares in February of 2019. This will increase our basic share count going forward. We expect our basic share count to average just under 46 million shares of common stock for the first quarter. These shares were included in diluted share count and periods of earnings so should not have an impact on our diluted share count. Our adjusted loss per diluted share for the fourth quarter was $0.06, which compared to an adjusted earnings per diluted share of $0.01 in the prior year's fourth quarter. For the full year, our 2018 adjusted earnings per share was $0.20, which was unchanged from $0.20 in 2017. Turning now to cash flow items and the balance sheet. Cash flow from operations for the fourth quarter was $6.4 million and it was $14 million for the year. Our net capital expenditures for the fourth quarter were $5.8 million and were $15.4 million for the year. Our free cash flow for the year was negative $1.4 million which was impacted by both specific working capital items and large tax payments during 2013. We currently expect our capital expenditures for 2019 to be between $9 million and $13 million a reduction of approximately 30% versus 2018 at the midpoint. Capital expenditures for 2019 include investments in manufacturing capacity at Repeat Precision to support the Purple Seal Express product line, investments in our tracer diagnostics business to improve field processes and the customer experience and limited investments in other parts of the business. As with G&A expense, we will continue to review opportunities to reduce our capital spending including leveraging supply chain partners and we are increasing internal capacity when possible. At December 31, 2018, we had $25.1 million in cash and total debt of $25.7 million which included $20 million drawn under our U.S. revolving credit facility. We also have up to $55 million in total availability under our revolving credit facilities bringing our total potential liquidity at December 31 to approximately $80.1 million. We expect our net interest expense to be between 0.5 million and 0.6 million in the first quarter and we expect our book effective tax rate for 2019 to be in the 10% to 15% range. As I mentioned briefly earlier, we implemented a new ERP system at the beginning of January. As part of the conversion process, we significantly reduced our payables during the fourth quarter to support our vendors and facilitate the transition. In addition, part of the ERP implementation process included keeping our books open a bit longer than usual to ensure we captured all invoices in the system. As a result our actual G&A came in slightly higher than the unaudited range that was included in our preannouncement from a few weeks ago. In 2019, we are incurring expenses that had previously been capitalized to support prior to going live on the new system. We have capitalized expense. We're now incurring expenses to support the new system that we expect those costs to moderate over time as we support the system internally. While any system transition includes a multitude of challenges, I'm very proud of the broad base team and NCS that has worked diligently over the past year to prepare for the implementation and to support the businesses we have made the transition In time, we believe that the new ERP system will provide managers across the organization with better and more timely visibility into financial and operational metrics which will support decision-making. We also expect that we'll be able to better improve or improve our working capital management and that the system will better facilitate future changes to our business. I'd like to take the next few minutes to talk about NCS' ability to generate free cash flow in 2019 and I refer you to Slide 17 of the investor presentation we posted last night. As we have not provided any full year EBITDA or adjusted EBITDA guidance, we'll simply bridge from an illustrative EBITDA to walk through sources and uses of cash to arrive at free cash flow. Several of these bridge items have a range and any summary figures will utilize the midpoint of the ranges provided. Starting from EBITDA, we add $12 million to 14 million in share-based compensation which we currently expect for the year. From there, we deduct approximately $5 million in cash interest, cash taxes and other items, which includes the litigation matters which we would categorize as non-recurring in nature. In our earnings release from last night, we note that the cash flows in the cash flow statement that we paid $22.4 million in cash taxes in 2018. This included the payment of taxes in both the U.S. and Canada which were deferred from 2017 into 2018 as well as the tax payments made during the year in 2018. For 2019, we find ourselves in a position where we are in an overpaid situation and therefore expect cash taxes to be minimal in 2019. Year-end working capital for NCS typically runs at approximately 30% of full year revenue. This may increase slightly by the end of 2019; market conditions are more favorable in the second half of the year than they were at the end of 2018, especially in Canada. As a result, we've shown a slight increase in net working capital here which we may be able to offset through normalization of accounts payable relative to the low levels at the end of 2018. I'll know that this part of the bridge does not include the $10 million contingent consideration amount, which I'll discuss in a minute, which is included as a current liability at December 31, 2018. The next bar represents net CapEx which we discussed earlier. The sum of all of these items would result in a free cash flow before the repeat earn out payment of EBITDA less approximately $4 million. Incorporating the earn out payment that we made in January results in free cash flow which will be calculated as EBITDA less approximately $14 million at the midpoint. I'll also note that over the last four months of 2018, Repeat Precision made cash distributions of $4.6 million of which $2.3 million went to our J.V. partner and our reflected in cash flow from financing activities. Following the earnout payment. The joint venture will direct its cash flow to funding near-term capital expenditures and also reducing some modest debt balance at Repeat Precision prior to resuming distributions. We do expect that repeat precision will be able to resume distributions later in 2019. I'll hand it over to Robert now for closing remarks.